AR and prostate carcinoma: This possible convergence suggests that metabolic rewiring and mitotic stability are not isolated processes but may cooperate to drive aggressive phenotypes, highlighting a rationale for strategies that co-target lipid metabolism and cell division pathways in AR-negative TNBC and AR-driven prostate cancer [39,40,41].